The role of oncology clinical practice guidelines in the managed care era.
The development of clinical practice guidelines in oncology presents unique problems and challenges due to the heterogeneity of disease presentations and the complexity of therapeutic decisions. Guidelines should incorporate not only standard outcomes measures such as survival but, if feasible, quality of life measures, patient preferences, and cost-effectiveness analyses. Although clinical guidelines are being promulgated as a means of assisting physicians in making therapeutic decisions, another purpose of guidelines implementation reflects the goals of managed care, ie, to promote practice conformity and reduce the cost of care. Methods to monitor physicians' adherence to guidelines are expected to increase as a means of ensuring compliance. This article reviews the process of developing two common types of guidelines used in oncology: path guidelines (using stage II breast cancer as a paradigm) and boundary guidelines (such as the ASCO growth factor guidelines).
Winn
R J
RJ
Section of Community Oncology, University of Texas, M. D. Anderson Cancer Center, Houston, USA.
D006801:Humans; D008329:Managed Care Programs / Q000191:economics*; D008495:Medical Oncology / Q000191:economics*; D017410:Practice Guidelines as Topic; D014481:United States